DECEMBER 16, 2019

CMV in Transplant Patients

Risk Factors, Therapeutic Strategies and New Directions

By Joy Curzio

By the age of 40, nearly half of U.S. adults are infected with cytomegalovirus (CMV), an infection that goes relatively unnoticed in healthy individuals but can be deadly to immunocompromised patients, according to the CDC.

image

Cytomegalovirus can remain latent for long periods in a person with a healthy immune system, but can be reactivated in someone who is immunocompromised, such as in a patient who undergoes solid-organ transplantation (SOT) or allogeneic hematopoietic cell